Priv.-Doz. Dr. Daniela Hartmann wins the “German Medical Award”
Great success also for VivaScope, the specialist for confocal laser scanning microscopy, because the VivaScope 2500 was part of it.
(Düsseldorf/Munich, 12/27/2021) Priv.-Doz. Dr. Daniela Hartmann, Ph.D. from the Clinic and Polyclinic for Dermatology and Allergology at Ludwig-Maximilians-University and Munich Clinic has won this year’s “German Medical Award” in the category “Medical Innovation Award Practice & Clinic Diagnostics”. By using artificial intelligence (AI) and confocal laser microscopy, users – even beginners – get faster and better results because tumors are clearly visible and easier to recognize through AI. Three partners have joined forces under the project name “SKIN-ID”, funded by the Free State of Bavaria, and are conducting research in this field: the Ludwig Maximilian University of Munich, the M3i agency and the equipment manufacturer VivaScope.
Dr. Daniela Hartmann, Senior Consultant at the Clinic and Polyclinic for Dermatology and Allergology at LMU Munich, says, “Especially in the area of basal cell carcionoma and squamous cell carcionoma, we can detect tumors very well, even those that are not easily visible, and usually remove them completely.”
he VivaScope GmbH has been on the market for over eighteen years. The Munich-based innovation company is a specialist in the development and worldwide distribution of confocal laser scanning microscopes in various areas of the medical and cosmetics industries.
Dr. Daniela Hartmann, Senior Consultant at the Clinic and Polyclinic for Dermatology and Allergology at LMU Munich, says, “Especially in the area of basal cell carcionoma and squamous cell carcionoma, we can detect tumors very well, even those that are not easily visible, and usually remove them completely.”
Especially the complete removal of a tumor is important, because otherwise the patient has to come several times, always new interventions are necessary. Sometimes, for example in the facial area, the wound must remain open for several days until there is a final result and the patient can be operated on further. This means stress for the patient but also for the healthcare system.
The advantage of using ex-vivo confocal laser scanning microscopy is obvious:
The results are available ultra-fast. During surgery, several steps and examinations that normally take days can be performed simultaneously in an instant.
Fresh tissue is stained with fluorescent dye. The physician receives information about what kind of tumor it is, whether everything has been excised and gets faster and more reliable information about further treatment. The physician thus learns directly whether further cutting is necessary or whether the wound can be closed. For the patient, this may save several interventions and multiple hospitalization days.
SKIN-ID is thus not only pursuing the goal of faster and safer results in the long term, but the use of artificial intelligence is also intended, above all, to relieve the burden on the pathologist. The pathologist can concentrate on difficult cases while the artificial intelligence is used to evaluate and assess them.
VivaScope technology is already in use at hospitals such as Goethe University Frankfurt, Helios Hospital Erfurt, Leipzig University Hospital and Augsburg University Hospital.
Within the framework of the funding project SKIN-ID / Bavarian State Ministry for Economic Affairs, Regional Development and Energy.
Automated evaluation of ex vivo confocal laser scanning microscopy for histopathological examination.
Attachements
Contact Person:
Other press releases
